New vaccine aims to snuff out the common cold
NCT ID NCT07399132
First seen Feb 13, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study is testing a new vaccine called APL-10456 to see if it is safe and can protect against rhinovirus, the main cause of the common cold. About 144 healthy volunteers, split into younger (18-54) and older (55+) groups, will receive either the vaccine or a placebo. The goal is to check for side effects and measure the immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHINOVIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emeritus Research
RECRUITINGMelbourne, Victoria, 3124, Australia
-
Veritus Research
RECRUITINGMelbourne, Victoria, 3153, Australia
Conditions
Explore the condition pages connected to this study.